Historique de carrière de Karen B. Chapman
Anciens postes connus de Karen B. Chapman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ONCOCYTE CORPORATION | Directeur Technique/Scientifique/R&D | 01/04/2011 | 22/03/2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Fondateur | - | - |
Formation de Karen B. Chapman
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Cornell University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Health Technology |
- Bourse
- Insiders
- Karen B. Chapman
- Expérience
